ICD-10-CM Billable Code

Z91.B

Personal risk factor of exposure to diethylstilbestrol

Clinical Classification Guidelines

Inclusion Terms

  • DES daughter or son
  • Personal risk factor of exposure to DES
  • Personal risk factor of exposure to DES in utero
  • Second generation DES exposure

Code Also

  • , associated conditions, such as:
  • conditions classifiable to C50.-
  • osteoporosis (M80.-)
  • premature menopause (E28.31-)

Medical Intelligence & Overview

ICD-10 code Z91.B refers to a personal risk factor related to exposure to diethylstilbestrol (DES), a synthetic form of estrogen that was used in the past to prevent pregnancy complications. This code is particularly relevant for individuals who were exposed to DES in utero or as part of second-generation exposure. Understanding this risk factor is crucial for ongoing health assessments and awareness of potential health implications associated with DES exposure.

Causes & Symptoms

Clinical Causes: Maternal use of diethylstilbestrol during pregnancy to prevent complications In utero exposure of a fetus to DES administered to the mother Second-generation exposure through offspring of women who took DES during pregnancy Environmental or occupational exposure, although less common

Key Symptoms: Reproductive system issues such as infertility or pregnancy complications in women Ectopic pregnancies or spontaneous abortions Increased risk of certain cancers, including clear cell adenocarcinoma of the vagina and cervix Possible fertility issues and reproductive health concerns in exposed individuals

Diagnostic & Treatment

Diagnosis Path: Diagnosis of DES exposure risk primarily involves reviewing maternal medical history and exposure history. Medical examinations may include gynecological assessments, screening for reproductive tract abnormalities, and regular cancer screenings. Although no specific laboratory test can confirm DES exposure, health practitioners consider exposure history as a significant factor in ongoing health monitoring.

Treatment Protocols: There is no specific treatment for DES exposure itself. Management focuses on the treatment of any health issues related to exposure, such as reproductive health problems or cancers. Regular screening and early detection of associated conditions are vital. Patients are often advised to undergo routine gynecological examinations and appropriate cancer screenings based on risk assessments.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z91.B a billable ICD-10 code?
Yes, Z91.B is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z91.B?
Clinical documentation must specify the nature of Personal risk factor of exposure to diethylstilbestrol and any associated comorbidities for accurate reporting.

Cite this Clinical Reference